ATLANTA and DENVER, April 8, 2011 /PRNewswire/ — At the 2011
American Association of Neurological Surgeons (AANS) Annual
Meeting, April 9-13 at the Colorado Convention Center, Elekta
(booth #1717) will highlight characteristics of Leksell Gamma
Knife® Perfexion™ that separate the system from other
radiosurgery solutions. These include its dedication to
intracranial cases, complete solution integration, industry-leading
accuracy, “shrink-wrap” dose conformity and extensively proven
clinical efficacy. Demonstrations of the system will emphasize that
Perfexion is designed to minimize the risk of human error and
radiation toxicity, while optimizing accuracy and dose
conformance.
The ability of Leksell Gamma Knife® to limit radiation
exposure to normal tissues was presented in an article published in
a recent issue of the Journal of Neurosurgery(1). Investigators
found that among three different treatment platforms, therapy
planned with Leksell Gamma Knife
would result in “much smaller normal brain volumes receiving any
particular dose” than plans developed with the two other
systems.
Extending the reach of Gamma Knife surgery
The opportunity to expand the clear clinical and safety
advantages of Perfexion is realized in the Extend™ system,
which also will be exhibited at the Elekta booth. Extend enables
multi-session hypofractionation of a therapy that is traditionally
a single-session treatment. Extend enables clinicians
to treat – over two to five fractions – patients with
larger tumors or lesions close to critical structures located in
the brain, skull base and in other head/neck regions. Extend
non-invasively immobilizes the patient’s head, making
hypofractionated therapy using Perfexion practical for these
cases.
Other meeting highlights
At AANS, Elekta also will exhibit several other solutio
‘/>”/>
